137 related articles for article (PubMed ID: 3160954)
1. Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites.
Glaser T; Traber J
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):211-5. PubMed ID: 3160954
[TBL] [Abstract][Full Text] [Related]
2. 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.
Dompert WU; Glaser T; Traber J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):467-70. PubMed ID: 2859533
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q 7821.
Glaser T; Rath M; Traber J; Zilles K; Schleicher A
Brain Res; 1985 Dec; 358(1-2):129-36. PubMed ID: 2866816
[TBL] [Abstract][Full Text] [Related]
4. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.
Traber J; Davies MA; Dompert WU; Glaser T; Schuurman T; Seidel PR
Brain Res Bull; 1984 Jun; 12(6):741-4. PubMed ID: 6541079
[TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
Waeber C; Schoeffter P; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):595-601. PubMed ID: 2975354
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain.
Shimizu H; Tatsuno T; Hirose A; Tanaka H; Kumasaka Y; Nakamura M
Life Sci; 1988; 42(24):2419-27. PubMed ID: 2897609
[TBL] [Abstract][Full Text] [Related]
9. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
Engel G; Göthert M; Hoyer D; Schlicker E; Hillenbrand K
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):1-7. PubMed ID: 2936965
[TBL] [Abstract][Full Text] [Related]
10. The distribution of serotonin binding sites in the hippocampal region of the rat brain. An autoradiographic study.
Köhler C
Neuroscience; 1984 Nov; 13(3):667-80. PubMed ID: 6527773
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
Ichida S; Hayashi T; Kita T; Murakami T
Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
[TBL] [Abstract][Full Text] [Related]
13. Characterization and regional distribution of serotonin S2-receptors in human brain.
Schotte A; Maloteaux JM; Laduron PM
Brain Res; 1983 Oct; 276(2):231-5. PubMed ID: 6627007
[TBL] [Abstract][Full Text] [Related]
14. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
McKernan RM; Quirk K; Jackson RG; Ragan CI
J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
[TBL] [Abstract][Full Text] [Related]
15. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
[TBL] [Abstract][Full Text] [Related]
16. Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit.
Mallorga P; Sugrue MF
Curr Eye Res; 1987 Mar; 6(3):527-32. PubMed ID: 3581873
[TBL] [Abstract][Full Text] [Related]
17. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
Hoyer D; Pazos A; Probst A; Palacios JM
Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.
Adachi H; Shoji T
Jpn J Pharmacol; 1986 Aug; 41(4):431-5. PubMed ID: 3773338
[TBL] [Abstract][Full Text] [Related]
19. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
20. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.
Müller-Schweinitzer E; Engel G
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
